Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...
Hosted on MSN14h
Therapeutic approach to treat virus-induced lung failure for severe COVID-19 shows promise in clinical trialA new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
News Medical on MSN21h
FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patientsA new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
Consuming alcohol to cope with stress has become more culturally acceptable since 2020, necessitating doctors more ...
News Medical on MSN7d
Could vitamin D help COVID-19 patients? Meta-analysis highlights potential ICU reductionVitamin D may lower ICU and intubation rates in COVID-19 patients, with significant benefits observed in older and severe ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days ...
New research indicates that people who contracted COVID-19 early in the pandemic faced a significantly elevated risk of heart ...
Discover new research which delves into the use of cardiac magnetic resonance imaging for detecting myocarditis after ...
New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...
The risks of thromboembolism—blood clots blocking blood flow to organs—following COVID-19 vaccination in patients with atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback